BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6422219)

  • 1. Cystathioninuria in patients with neuroblastoma.
    Rajnherc JR; van Gennip AH; Abeling NG; van der Zee JM; Voûte PA
    Med Pediatr Oncol; 1984; 12(2):81-4. PubMed ID: 6422219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary cystathioninuria due to vitamin B 6 deficiency in familial neuroblastoma].
    Plöchl E
    Padiatr Padol; 1976; 11(2-2):444-68. PubMed ID: 967508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystathioninuria in patients with neuroblastoma or ganglioneuroblastoma. Its correlation to vanilmandelic acid excretion and its value in diagnosis and therapy.
    Geiser CF; Efron ML
    Cancer; 1968 Oct; 22(4):856-60. PubMed ID: 5212308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical monitoring of children with neuroblastoma.
    Abeling NG; van Gennip AH; Overmars H; Voûte PA
    Radiother Oncol; 1986 Sep; 7(1):27-35. PubMed ID: 3095895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Various forms of cystathioninuria].
    Endres W
    Fortschr Med; 1982 Mar; 100(11):460-4. PubMed ID: 7076074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
    Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
    Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxal-5'-phosphate determination by a sensitive micromethod in human blood, urine and tissues; its relation to cystathioninuria in neuroblastoma and biliary atresia.
    Shin YS; Rasshofer R; Friedrich B; Endres W
    Clin Chim Acta; 1983 Jan; 127(1):77-85. PubMed ID: 6825312
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical studies on familial neuroblastoma].
    Plöchl E
    Padiatr Padol; 1978; 13(2):123-36. PubMed ID: 643289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of urinary vanillactic acid and plasma dihydroxyphenylalanine as markers of non-secreting neuroblastoma by high-performance liquid chromatography with electrochemical detection.
    Jouve J; Bakri D; Herault J; Muh JP
    J Chromatogr; 1991 Jul; 567(2):331-41. PubMed ID: 1939466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary cystathionine, catecholamine, and metabolites in patients with neuroblastoma.
    Helson L; Fleisher M; Bethune V; Murphy ML; Schwartz MK
    Clin Chem; 1972 Jul; 18(7):613-5. PubMed ID: 5037905
    [No Abstract]   [Full Text] [Related]  

  • 11. Gas chromatographic determination of urinary vanilglycolic acid, vanilglycol, vanilacetic acid and vanillactic acid-chemical parameters for the diagnosis of neurogenic tumours and the evaluation of their treatment.
    Wadman SK; Ketting D; Voûte PA
    Clin Chim Acta; 1976 Oct; 72(1):49-68. PubMed ID: 184988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
    Tuchman M; Stoeckeler JS
    Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis.
    Fitzgibbon MC; Tormey WP
    Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():1-11. PubMed ID: 8154845
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
    Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
    Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y; Desager JP; Harvengt C
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
    LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
    Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
    [No Abstract]   [Full Text] [Related]  

  • 17. Occurrence of secondary cystathioninuria in children with inherited metabolic disorders, liver diseases, neoplasms, cystic fibrosis and celiac disease.
    Endres W; Wuttge B
    Eur J Pediatr; 1978 Aug; 129(1):29-35. PubMed ID: 210019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
    Tuchman M; Robison LL; Maynard RC; Ramnaraine ML; Krivit W
    Clin Biochem; 1985 Jun; 18(3):176-9. PubMed ID: 4039636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Newborn with Distended Abdomen.
    Selvaratnam R; Karger AB
    Clin Chem; 2016 Aug; 62(8):1061-4. PubMed ID: 27471243
    [No Abstract]   [Full Text] [Related]  

  • 20. Excretion of octopamine metabolites in neuroblastoma.
    Couch MW; Greer DM; Williams CM
    Clin Chim Acta; 1986 Jul; 158(1):109-14. PubMed ID: 3091293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.